Tag: drug therapy

atrial fibrillation

ESC 2019: Catheter ablation may be up to 10 times more...

Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...

CABANA finds reduced AF and better quality of life after ablation...

Catheter ablation for atrial fibrillation leads to a reduction in atrial fibrillation, better quality of life and lower hospitalisations than medical therapy, but does...
Evolocumab Amgen

Evolocumab becomes first FDA-approved PCSK9 inhibitor for prevention of MI and...

Following a priority review by US Food and Drug Administration (FDA), evolocumab has received FDA approval in the USA. The drug is a PCSK9...